Close

Analyst Ratings for Immunomedics (IMMU) [Buys]

IMMU Rating Summary

  |   Expand Research on IMMU
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 7.2 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/5/2020 Barclays
» Updated 8/6/2020
Peter Lawson New Coverage Overweight
(N/A)
52.00
(48.00)
30.38
(87.86)
189.2% Details
12/20/2019 BofA Securities
» Updated 7/1/2020
Tazeen Ahmad New Coverage Buy
(N/A)
44.00
(37.00)
20.00
(87.86)
339.3% Details